Literature DB >> 8833040

A rapid activation assay for human eosinophils based on adhesion to immobilized ICAM-1, VCAM-1 and IgG.

D Fattah1, K R Page, S Bezbaruah, R C Priest, C M Horgan, R Solari.   

Abstract

Interleukin 5 (IL-5) is a T-cell derived cytokine that induces eosinophil growth and differentiation in both mouse and human bone marrow cultures. Elevated levels of IL-5 as well as eosinophils have been detected in the sputum and Bronchoalveolar lavage (BAL) fluids of asthmatics. Since the recruitment of inflammatory cells to tissues requires the participation of adhesion molecules, we have developed a rapid and sensitive assay to examine the effect of IL-5 and other activation stimuli on eosinophil adhesion to recombinant intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1). Human recombinant IL-5, granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin 3 (IL-3), tumour necrosis factor alpha (TNF-alpha), RANTES, MCP-3, C5a, PAF, fMLP, PMA and ConA all induced adhesion of purified eosinophils obtained from normal donors to ICAM-1 and VCAM-1 in a dose and time dependent manner. Adhesion was rapid, within 15 minutes of culture at 37 degrees C, and plateaued within 30 minutes. Activated eosinophils also adhered rapidly to immobilized IgG via the type II Fc gamma receptor (CD32). Analysis of the effect of IL-5 on surface molecule expression by FACS analysis revealed increased expression of CD11b molecules and decreased expression of L-selectin, but no change in the expression of CD11a, CD18, CD29, CD49d and CD32. We also show that Mac-i plays an important role in the regulation of eosinophil activation, since antibodies to CD11b can block IL-5 induced adhesion to IgG and IL-5 induced degranulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833040     DOI: 10.1006/cyto.1996.0034

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains.

Authors:  B P England; P Balasubramanian; I Uings; S Bethell; M J Chen; P J Schatz; Q Yin; Y F Chen; E A Whitehorn; A Tsavaler; C L Martens; R W Barrett; M McKinnon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel.

Authors:  Xiangdong Zhu; Jonathan Learoyd; Sanober Butt; Lilly Zhu; Peter V Usatyuk; Viswanathan Natarajan; Nilda M Munoz; Alan R Leff
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

Review 3.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Effects of dexamethasone on TNF-alpha-induced release of cytokines from purified human blood eosinophils.

Authors:  Iain Uings; Ilaria Puxeddu; Vladislav Temkin; Susan J Smith; Dilniya Fattah; Keith P Ray; Francesca Levi-Schaffer
Journal:  Clin Mol Allergy       Date:  2005-04-27

5.  Human eosinophil-airway smooth muscle cell interactions.

Authors:  J M Hughes; C A Arthur; S Baracho; S M Carlin; K M Hawker; P R Johnson; C L Armour
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

6.  An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.

Authors:  M McKinnon; K Page; I J Uings; M Banks; D Fattah; A E Proudfoot; P Graber; C Arod; R Fish; T N Wells; R Solari
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.